AHPA submits comments on mandatory product listing language in FDALSA
May 25, 2022
While affirming opposition to mandatory product listing, the American Herbal Products Association offered its feedback and suggested revisions to the discussion draft of the FDA Safety and Landmark Advancements (FDASLA) Act published by the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP).